Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Net Income (Quarterly): -22.04M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -22.04M |
| June 30, 2023 | -26.50M |
| March 31, 2023 | -24.56M |
| December 31, 2022 | -23.61M |
| September 30, 2022 | -21.98M |
| June 30, 2022 | -22.64M |
| March 31, 2022 | -23.53M |
| December 31, 2021 | -18.18M |
| Date | Value |
|---|---|
| September 30, 2021 | -34.39M |
| June 30, 2021 | -8.552M |
| March 31, 2021 | -5.851M |
| December 31, 2020 | -4.608M |
| September 30, 2020 | -5.577M |
| June 30, 2020 | -5.198M |
| March 31, 2020 | -3.471M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-34.39M
Minimum
Sep 2021
-3.471M
Maximum
Mar 2020
-16.71M
Average
-21.98M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -113.82M |
| Immunogen Inc (DELISTED) | 30.75M |
| AbbVie Inc | 1.369B |
| Assure Holdings Corp | -9.063M |
| Harpoon Therapeutics Inc (DELISTED) | -1.802M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.28M |
| EPS Diluted (Quarterly) | -0.44 |
| Enterprise Value | 537.68M |
| Earnings Yield | -14.50% |